Study to Evaluate Safety and Tolerability, Pharmacodynamic Effects and Exploratory Efficacy of a Vaccine Against Essential Hypertension
This study has been completed.
Sponsor:
Cytos Biotechnology AG
Information provided by:
Cytos Biotechnology AG
ClinicalTrials.gov Identifier:
NCT00701649
First received: June 18, 2008
Last updated: December 1, 2009
Last verified: December 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | November 2009 |
| Primary Completion Date: | March 2009 (Final data collection date for primary outcome measure) |